Statement Of Cash Flows [Abstract]

Xbrane Biopharma - Filing #702449

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for decrease (increase) in trade and other receivables
22 671 SEK
32 697 SEK
Cash flows from (used in) financing activities [abstract]
Payments for share issue costs
24 231 SEK
20 584 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.